Cancer stem-neuroendocrine cells in an atypical carcinoid case report

被引:4
作者
Masciale, Valentina [1 ]
Grisendi, Giulia [2 ]
Banchelli, Federico [3 ]
D'Amico, Roberto [3 ]
Maiorana, Antonino [4 ]
Morandi, Uliano [1 ]
Dominici, Massimo [2 ]
Aramini, Beatrice [1 ]
机构
[1] Univ Modena & Reggio Emilia, Div Thorac Surg, Dept Med & Surg Sci, Via Largo del Pozzo 71, I-41124 Modena, Italy
[2] Univ Modena & Reggio Emilia, Div Oncol, Dept Med & Surg Sci, Modena, Italy
[3] Univ Modena & Reggio Emilia, Ctr Stat, Dept Med & Surg Sci, Modena, Italy
[4] Univ Modena & Reggio Emilia, Inst Pathol, Dept Med & Surg Sci, Modena, Italy
关键词
Cancer stem cells (CSCs); neuroendocrine cells tumor (NETs); atypical carcinoid; carcinoid tumors (TCs); case report; TUMORS; CLASSIFICATION; MANAGEMENT;
D O I
10.21037/tlcr.2019.12.07
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Lung neuroendocrine cells tumor (NET) classification and diagnosis, particularly for typical and atypical carcinoids, are complicated by a variable natural history and nonspecific symptoms. Mechanisms for the development and progression of well-differentiated lung NETs are still unclear. An accurate and timely diagnosis can ensure the implementation of appropriate treatment and impact on prognosis. One of the main unclear point is the definition of these cells' composition. In fact, it is known that carcinoids are mainly constituted by neuroendocrine cells. Aim of our report is to show for the first time the presence of a high percentage of cancer stem cells (CSCs) in an atypical carcinoid. The ALDEFLUOR assay was used to identify and sort ALDH(high) and ALDH(low)( )human lung cancer cells following tissue digestion. SOX2 was additionally determined by immunohistochernistry. All specimens contained the 53.10% of ALDHhigh cells among all viable lung cancer cells, which indicates that more than half of the entire tumor cell population was composed by CSCs. As expected also in immunohistochemistry, about a half of the nuclei of the cells were positive for SOX2. We strongly support the hypothesis of the presence of cancer stem-neuroendocrine cells (CSCs-NETs) as subpopulation in these types of tumors.
引用
收藏
页码:1157 / 1162
页数:6
相关论文
共 15 条
[1]   Aldehyde dehydrogenases in cancer stem cells: potential as therapeutic targets [J].
Clark, David W. ;
Palle, Komaraiah .
ANNALS OF TRANSLATIONAL MEDICINE, 2016, 4 (24)
[2]   Neuroendocrine Tumors of the Lung: Current Challenges and Advances in the Diagnosis and Management of Well-Differentiated Disease [J].
Hendifar, Andrew E. ;
Marchevsky, Alberto M. ;
Tuli, Richard .
JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (03) :425-436
[3]   Aldehyde Dehydrogenase 1 Is a Marker for Normal and Malignant Human Colonic Stem Cells (SC) and Tracks SC Overpopulation during Colon Tumorigenesis [J].
Huang, Emina H. ;
Hynes, Mark J. ;
Zhang, Tao ;
Ginestier, Christophe ;
Dontu, Gabriela ;
Appelman, Henry ;
Fields, Jeremy Z. ;
Wicha, Max S. ;
Boman, Bruce M. .
CANCER RESEARCH, 2009, 69 (08) :3382-3389
[4]   Small cell lung cancer (SCLC): no treatment advances in recent years [J].
Koinis, Filippos ;
Kotsakis, Athanasios ;
Georgoulias, Vasileios .
TRANSLATIONAL LUNG CANCER RESEARCH, 2016, 5 (01) :39-50
[5]   Targeting ALDH1A1 by disulfiram/copper complex inhibits non-small cell lung cancer recurrence driven by ALDH-positive cancer stem cells [J].
Liu, Xinwei ;
Wang, Lihui ;
Cui, Wei ;
Yuan, Xiangzhong ;
Lin, Lulu ;
Cao, Qi ;
Wang, Nannan ;
Li, Yi ;
Guo, Wei ;
Zhang, Xun ;
Wu, Chunfu ;
Yang, Jingyu .
ONCOTARGET, 2016, 7 (36) :58516-58530
[6]   Advanced typical and atypical carcinoid tumours of the lung: management recommendations [J].
Melosky, B. .
CURRENT ONCOLOGY, 2018, 25 :S86-S93
[7]   Human bronchial carcinoid tumor initiating cells are targeted by the combination of acetazolamide and sulforaphane [J].
Mokhtari, Reza Bayat ;
Baluch, Narges ;
Morgatskaya, Evgeniya ;
Kumar, Sushil ;
Sparaneo, Angelo ;
Muscarella, Lucia Anna ;
Zhao, Sheyun ;
Cheng, Hai-Ling ;
Das, Bikul ;
Yeger, Herman .
BMC CANCER, 2019, 19 (01)
[8]   Nothing But NET: A Review of Neuroendocrine Tumors and Carcinomas [J].
Oronsky, Bryan ;
Ma, Patrick C. ;
Morgensztern, Daniel ;
Carter, Corey A. .
NEOPLASIA, 2017, 19 (12) :991-1002
[9]   Classification of pulmonary neuroendocrine tumors: new insights [J].
Pelosi, Giuseppe ;
Sonzogni, Angelica ;
Harari, Sergio ;
Albini, Adriana ;
Bresaola, Enrica ;
Marchio, Caterina ;
Massa, Federica ;
Righi, Luisella ;
Gatti, Gaia ;
Papanikolaou, Nikolaos ;
Vijayvergia, Namrata ;
Calabrese, Fiorella ;
Papotti, Mauro .
TRANSLATIONAL LUNG CANCER RESEARCH, 2017, 6 (05) :513-529
[10]   A common classification framework for neuroendocrine neoplasms: an International Agency for Research on Cancer (IARC) and World Health Organization (WHO) expert consensus proposal [J].
Rindi, Guido ;
Klimstra, David S. ;
Abedi-Ardekani, Behnoush ;
Asa, Sylvia L. ;
Bosman, Frederik T. ;
Brambilla, Elisabeth ;
Busam, Klaus J. ;
de Krijger, Ronald R. ;
Dietel, Manfred ;
El-Naggar, Adel K. ;
Fernandez-Cuesta, Lynnette ;
Kloeppel, Guenter ;
McCluggage, W. Glenn ;
Moch, Holger ;
Ohgaki, Hiroko ;
Rakha, Emad A. ;
Reed, Nicholas S. ;
Rous, Brian A. ;
Sasano, Hironobu ;
Scarpa, Aldo ;
Scoazec, Jean-Yves ;
Travis, William D. ;
Tallini, Giovanni ;
Trouillas, Jacqueline ;
van Krieken, J. Han ;
Cree, Ian A. .
MODERN PATHOLOGY, 2018, 31 (12) :1770-1786